Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, United States of America.
Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, United States of America.
Clin Psychol Rev. 2022 Feb;91:102110. doi: 10.1016/j.cpr.2021.102110. Epub 2021 Nov 26.
Only a small minority of people with substance use disorders (SUDs) receive treatment. A focus on abstinence is pervasive in SUD treatment, defining success in both research and practice, and punitive measures are often imposed on those who do not abstain. Most adults with SUD do not seek treatment because they do not wish to stop using substances, though many also recognize a need for help. This narrative review considers the need for increased research attention on nonabstinence psychosocial treatment of SUD - especially drug use disorders - as a potential way to engage and retain more people in treatment, to engage people in treatment earlier, and to improve treatment effectiveness. We describe the development of nonabstinence approaches within the historical context of SUD treatment in the United States, review theoretical and empirical rationales for nonabstinence SUD treatment, and review existing models of nonabstinence psychosocial treatment for SUD among adults to identify gaps in the literature and directions for future research. Despite significant empirical support for nonabstinence alcohol interventions, there is a clear gap in research examining nonabstinence psychosocial treatment for drug use disorders. Future research must test the effectiveness of nonabstinence treatments for drug use and address barriers to implementation.
只有少数物质使用障碍(SUD)患者接受治疗。在 SUD 治疗中,对戒除的关注是普遍存在的,这在研究和实践中都定义了成功,并且经常对那些不戒除的人施加惩罚措施。大多数患有 SUD 的成年人不寻求治疗,因为他们不想停止使用物质,尽管许多人也认识到需要帮助。本叙述性评论考虑了增加对非戒除性心理社会治疗 SUD 的研究关注的必要性,特别是药物使用障碍,这是一种潜在的方法,可以吸引和留住更多的人接受治疗,让人们更早地接受治疗,并提高治疗效果。我们在 SUD 治疗的美国历史背景下描述了非戒除方法的发展,回顾了非戒除 SUD 治疗的理论和经验依据,并回顾了现有的成人 SUD 非戒除心理社会治疗模型,以确定文献中的差距和未来研究的方向。尽管有大量关于非戒除酒精干预的实证支持,但在研究非戒除药物使用障碍的心理社会治疗方面存在明显差距。未来的研究必须测试非戒除药物治疗的有效性,并解决实施障碍。